Hybrid coronary revascularization (HCR) provides satisfactory long-term outcomes in patients with multivessel coronary artery disease, similar to those of off-pump coronary artery bypass grafting (CABG) and better than those of percutaneous coronary intervention (PCI), according to a new study.